FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Nucleotide patents



      
           
This page is updated frequently with new Nucleotide-related patent applications. Subscribe to the Nucleotide RSS feed to automatically get the update: related Nucleotide RSS feeds. RSS updates for this page: Nucleotide RSS RSS


Date/App# patent app List of recent Nucleotide-related patents
12/11/14
20140366223
 Methods for generating transgenic plants patent thumbnailMethods for generating transgenic plants
This invention provides a method for generating transgenic plants with a low copy number. Plant cells are transformed with polynucleotides containing transcriptional cassettes designed to trigger silencing of a gene which is essential for the plant cell to survive the transformation and regeneration process.
12/11/14
20140366220
 Compositions and methods for increased expression in sugar cane patent thumbnailCompositions and methods for increased expression in sugar cane
A sugar cane plant cell comprising a recombinant nucleic acid molecule is provided, the recombinant nucleic acid molecule comprising a nucleotide sequence of interest, a promoter and the nucleotide sequence of seq id no:1, wherein the promoter is downstream of and in operative association with the nucleotide sequence of seq id no:1 and upstream of and in operative association with the nucleotide sequence of interest, and the nucleotide sequence of interest is expressed at a level at least about 6 times greater than the level of expression of said nucleotide sequence of interest in a control. Additionally, a method of increasing the expression of a nucleotide sequence of interest in a sugar cane plant cell using the recombinant nucleic acid molecule of the invention is provided..
12/11/14
20140366218
 Soybean bb13 promoter and its use in embryo-specific expression of transgenic genes in plants patent thumbnailSoybean bb13 promoter and its use in embryo-specific expression of transgenic genes in plants
The invention relates to gene expression regulatory sequences from soybean, specifically to the promoter of a soybean bowman-birk type proteinase isoinhibitor gene (bbi3) and fragments thereof and their use in promoting the expression of one or more heterologous nucleotide sequences in an embryo-specific manner in plants. The invention further discloses compositions, polynucleotide constructs, transformed host cells, transgenic plants and seeds containing the recombinant construct with the promoter, and methods for preparing and using the same..
12/11/14
20140366216
 Stress resistant plants patent thumbnailStress resistant plants
Stress tolerance in plants and plant cells is achieved by using nucleotide sequences encoding enzymes involved in the nad salvage synthesis pathway and/or the nad de novo synthesis pathway e.g. For overexpression in plants..
12/11/14
20140364589
 Brtcp24 gene useful for controlling growth of cabbage and application thereof patent thumbnailBrtcp24 gene useful for controlling growth of cabbage and application thereof
A brtcp24 gene for controlling the growth of chinese cabbage and its applications. The brtcp24 gene has the nucleotide sequence shown in seq id no.
12/11/14
20140364487
 New c5a binding nucleic acids patent thumbnailNew c5a binding nucleic acids
The present invention is related to a nucleic acid molecule capable of binding to human c5a, wherein the nucleic acid molecule comprises a central stretch of nucleotides, wherein the central stretch of nucleotides comprises a nucleotide sequence of 5′ augn1ggugkun2n3rggghugukgggn4gn5cgacgca 3′ [seq id no: 61], wherein n1 is u or du, n2 is g or dg, n3 is a or da, n4 is u or du, n5 is u or du and g, a, u, c, h, k, and r are ribonucleotides, and du, dg and da are 2′-deoxyribonucleotides.. .
12/11/14
20140364482
 Reduced size self-delivering rnai compounds patent thumbnailReduced size self-delivering rnai compounds
The present invention relates to rnai constructs with minimal double-stranded regions, and their use in gene silencing. Rnai constructs associated with the invention include a double stranded region of 8-14 nucleotides and a variety of chemical modifications, and are highly effective in gene silencing..
12/11/14
20140364340
 Rationally designed, synthetic antibody libraries and uses therefor patent thumbnailRationally designed, synthetic antibody libraries and uses therefor
The present invention overcomes the inadequacies inherent in the known methods for generating libraries of antibody-encoding polynucleotides by specifically designing the libraries with directed sequence and length diversity. The libraries are designed to reflect the preimmune repertoire naturally created by the human immune system and are based on rational design informed by examination of publicly available databases of human antibody sequences..
12/11/14
20140364324
 Nanopore sequencing using charge blockade labels patent thumbnailNanopore sequencing using charge blockade labels
The invention relates to devices and methods for nanopore sequencing. The invention includes compositions and methods of nucleic acid sequencing using a single polymerase enzyme complex comprising a polymerase enzyme and a template nucleic acid attached proximal to a nanopore, and nucleotide analogs in solution comprising charge blockade label that are attached to the polyphosphate portion of the nucleotide analog such that the charge blockade labels are cleaved when the nucleotide analog is incorporated into a growing nucleic acid and the charge blockade label is detected by the nanopore to determine the presence and identity of the incorporated nucleotide and thereby determine the sequence of a template nucleic acid..
12/11/14
20140364323
 Multi-sample indexing for multiplex genotyping patent thumbnailMulti-sample indexing for multiplex genotyping
A method for determining the presence of multiple nucleotide sequences of interest in multiple samples while preserving the identity of each sample, by contacting the samples with a plurality of probe sets. The probes are designed to indicate the presence of the sequences of interest and the identity of the sample containing the sequence of interest in complex mixtures.
12/11/14
20140363876
Kits and methods for generating 5' capped rna
The present invention relates to kits and methods for efficiently generating 5′ capped rna having a modified cap nucleotide and for use of such modified-nucleotide-capped rna molecules. In particular, the present invention provides kits and methods for capping rna using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme.
12/11/14
20140363853
Nucleotide cloning methods
Methods of cloning insert sequences into cloning vectors with high efficiency and in the correct orientation are described. In one aspect, the invention features a method of producing a plasmid comprising an insert fragment and a vector fragment in a predetermined orientation.
12/11/14
20140363852
Methods and apparatus for synthesizing nucleic acids
The invention provides improved methods for synthesizing polynucleotides, such as dna and rna, using enzymes and specially designed nucleotide analogs. Using the methods of the invention, specific sequences of polynucleotides can be synthesized de novo, base by base, in an aqueous environment, without the use of a nucleic acid template.
12/11/14
20140363851
Methods and apparatus for synthesizing nucleic acids
The invention provides improved methods for synthesizing polynucleotides, such as dna and rna, using enzymes and specially designed nucleotide analogs. Using the methods of the invention, specific sequences of polynucleotides can be synthesized de novo, base by base, in an aqueous environment, without the use of a nucleic acid template.
12/11/14
20140363850
Methods to mutate circular deoxyribonucleotides
The invention provides improved mutagenic plasmids and a method for making and using them. In one embodiment a cyclic mutagenic nucleic acid is replicated to form interlocking, digestibly separable duplex or simplex rings; and then one or more of the interlocked rings are cleaved selectively by means of a restriction enzyme to liberate an intact duplex or simplex ring.
12/11/14
20140363849
Method for improving nucleic acid synthesis reaction
Provided are the following: a method, for improving reactivity of a nucleic acid synthesis reaction, comprising a step for adding an ω-amino acid to a reaction solution; a composition, for a nucleic acid synthesis reaction, comprising dna polymerase, reaction buffer, at least one primer, at least one deoxyribonucleotide triphosphate, and an ω-amino acid; and a reaction buffer, for a nucleic acid synthesis reaction, comprising an ω-amino acid.. .
12/11/14
20140363840
Method of determining the viability of at least one cell
This disclosure provides a method of determining the viability of at least one cell via quantification of nicotinamide adenine dinucleotide (phosphate) (nad(p)h), flavin adenine dinucleotide (fad), and/or collagen. The method includes the steps of contacting the at least one cell with light having a wavelength of from 700 to 900 nm, using two photon excitation, or from 335 to 400 nm, using one photon excitation, to induce an optical response from the nad(p)h, fad, and/or collagen and measuring the optical response.
12/11/14
20140363812
Method for detecting nucleosomes containing nucleotides
The invention relates to a method for detecting and measuring the presence of mono-nucleosomes and oligo-nucleosomes and nucleosomes that contain particular nucleotides and the use of such measurements for the detection and diagnosis of disease. The invention also relates to a method of identifying nucleosome associated nucleotide biomarkers for the detection and diagnosis of disease and to biomarkers identified by said method..
12/11/14
20140363811
Compositions for detecting alicyclobacillus microorganisms
The invention provides nucleic acids, collections of nucleic acids, supports, assay kits, and methods for the sensitive and specific detection of microorganisms in a foodstuff. The nucleic acid comprises a nucleotide sequence selected from the group consisting of seq id nos: 1-15 and having a length of no more than 35 nucleotides..
12/11/14
20140363561
Tal-mediated transfer dna insertion
The invention relates to methods for stably integrating a desired polynucleotide into a plant genome.. .
12/11/14
20140363538
Use of polypeptides having protease activity in animal feed and detergents
The present invention relates to the use of isolated polypeptides having protease activity and isolated polynucleotides encoding the polypeptides in animal feed and detergents. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides in e.g.
12/11/14
20140363446
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against vsig1, ildr1, loc253012, ai216611, c1orf32 or fxyd3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages.
12/11/14
20140363436
Diagnosing and treating iga nephropathy
Provided are methods of diagnosing iga nephropathy in a subject. Optionally, the methods comprise isolating an igg from the subject and determining whether the igg binds to a galactose-deficient iga1.
12/11/14
20140363415
Compositions and methods comprising glycyl-trna synthetases having non-canonical biological activities
Isolated glycyl-trna synthetase polypeptides and polynucleotides having non-canonical biological activities are provided, as well as compositions and methods related thereto.. .
12/11/14
20140361911
Methods and systems for storing sequence read data
The present invention generally relates to storing sequence read data. The invention can involve obtaining a plurality of sequence reads from a sample, identifying one or more sets of duplicative sequence reads within the plurality of sequence reads, and storing only one of the sequence reads from each set of duplicative sequence reads in a text file using nucleotide characters..
12/11/14
20140360403
Organic-inorganic composite materials as a result of biomineralization
A method for producing organic-inorganic composite materials includes at least one biomineralising protein and/or polypeptide-encoding recombinant polynucleotide being introduced into at least one host cell, preferably from the class of slime moulds, and the expressed protein and/or polypeptide influencing the formation of inorganic particles in an extracellular matrix of the host cell.. .
12/04/14
20140359901
Seed-specific promoter in cotton
The present application discloses a(n) (isolated) nucleic acid sequence comprising a nucleotide sequence selected from (a) seq id no: 1 or a fragment thereof, wherein said fragment comprises at least 400 consecutive nucleotides of seq id no: 1 and has seed-specific promoter activity; (b) a nucleotide sequence with at least 80% sequence identity with seq id no: 1 and having seed-specific promoter activity; (c) a nucleotide sequence hybridizing under stringent conditions to the nucleotide sequence of (a) or (b); and (d) a nucleotide sequence complementary to the nucleotide sequence of any one of (a) to (c). Further disclosed herein is a chimeric gene comprising the (isolated) nucleic acid described herein operably linked to a nucleic acid coding for an expression product of interest, and optionally a transcription termination and polyadenylation sequence.
12/04/14
20140357855
Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
The invention relates to oligonucleotides for inducing skipping of exon 53 of the dystrophin gene. The invention also relates to methods of inducing exon 53 skipping using the oligonucleotides..
12/04/14
20140357849
Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
The present invention relates to compositions and methods for preparing splice variants of tnfalpha receptor (tnfr) in vivo or in vitro, and the resulting tnfr protein variants. Such variants may be prepared by controlling the splicing of pre-mrna molecules and regulating protein expression with splice switching oligonucleotides or splice switching oligomers (ssos).
12/04/14
20140357727
Fatty alcohol forming acyl reductase (far) variants and methods of use
The present disclosure provides methods useful for producing fatty alcohol compositions from recombinant host cells. The disclosure further provides fatty acyl-coa reductase (far) variant enzymes, polynucleotides encoding the far variant enzymes, and vectors and host cells comprising polynucleotides encoding the far variant enzymes..
12/04/14
20140357700
Methods and compositions for the specific inhibition of gene expression by double-stranded rna
The invention is directed to compositions and methods for selectively reducing the expression of a gene product from a desired target gene in a cell, as well as for treating diseases caused by the expression of the gene. More particularly, the invention is directed to compositions that contain double stranded rna (“dsrna”), and methods for preparing them, that are capable of reducing the expression of target genes in eukaryotic cells.
12/04/14
20140357698
Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
The invention relates to oligonucleotides for inducing skipping of exon 53 of the dystrophin gene. The invention also relates to methods of inducing exon 53 skipping using the oligonucleotides..
12/04/14
20140357566
Identification and molecular characterisation of proteins, expressed in the ixodes ricinus salivary glands
The invention relates to a new polynucleotide which encodes a polypeptide expressed in the salivary glands of ticks, more particularly the ixodes ricinus arthropod tick, during the slow-feeding phase of the blood meal have, said polynucleotide and related polypeptide may be used in different constructions and for different applications which are also included in the present invention.. .
12/04/14
20140357515
Method and kit for identification and quantification of single-strand target nucleic acid
A method for identification and quantification of at least one single-stranded target nucleic acid and a kit for detection of at least one single-stranded target nucleic acid in a sample are described. The method includes contacting at least one solid carrier that includes at least one capture oligonucleotide immobilized thereon with at least one complementary-strand oligonucleotide, at least one single-stranded target nucleic acid, and at least one reporter oligonucleotide that includes a label.
12/04/14
20140357487
Plants having increased tolerance to herbicides
The present invention refers to a method for controlling undesired vegetation at a plant cultivation site, the method comprising the steps of providing, at said site, a plant that comprises at least one nucleic acid comprising a nucleotide sequence encoding a wild-type hydroxyphenyl pyruvate dioxygenase or a mutated hydroxyphenyl pyruvate dioxygenase (mut-hppd) which is resistant or tolerant to a coumarone-derivative herbicide and/or a nucleotide sequence encoding a wild-type homogentisate solanesyl transferase or a mutated homogentisate solanesyl transferase (mut-hst) which is resistant or tolerant to a coumarone-derivative herbicide, and applying to said site an effective amount of said herbicide. The invention further refers to plants comprising mut-hppd, and methods of obtaining such plants..
12/04/14
20140356957
Biological pacemaker
Disclosed are methods and systems for modulating electrical behavior of cardiac cells. Preferred methods include administering a polynucleotide or cell-based composition that can modulate cardiac contraction to desired levels, i.e., the administered composition functions as a biological pacemaker..
12/04/14
20140356944
Biocatalysts and methods for the synthesis of (s)-3-(1-aminoethyl)-phenol
The present disclosure provides engineered transaminase polypeptides having improved properties as compared to naturally occurring transaminases including the ability of converting the substrate, 3′-hydroxyacetophenone to (s)-3-(1-aminoethyl)-phenol in enantiomeric excess and high percentage conversion. Also provided are polynucleotides encoding the engineered transaminases, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases to synthesize (s)-3-(1-aminoethyl)-phenol and related compounds useful in the production of active pharmaceutical ingredients..
12/04/14
20140356926
Novel sesquiterpene synthase gene and protein
The invention relates to sesquiterpene synthases and methods for their production and use. Particularly, the invention provides nucleic acids comprising the nucleotide sequence of citrus valencene synthase (cvs) which codes for at least one cvs.
12/04/14
20140356917
Process for producing lipids suitable for biofuels
The present invention provides a cost effective biotechnological process for production of bio-fuels from isolated and characterized microalgae. The algal strains used in the present invention having higher biomass, higher lipid productivity, higher ph and temperature tolerance are selected from the group consisting of chlorella vulgaris ioc-1, chlorella vulgaris ioc-2, chlorella kessleri, botrococcus bruni, dunaliella salina and nannochloris oculat or a combination thereof having 95-100% similarity with 18s ribosomal nucleic acids nucleotide sequences (rdna) given for seq.
12/04/14
20140356906
Methods and products for transfecting cells
The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods for inducing cells to express proteins and for reprogramming and gene-editing cells using rna are disclosed.
12/04/14
20140356878
Primers and methods for determining rhd zygosity
Provided herein are primers comprising a nucleotide sequence complementary to a portion of a rhd gene. Also provided herein are methods of determining a rhd zygosity in a subject.
12/04/14
20140356869
Single nucleotide polymorphisms associated with dietary weight loss
The present invention relates to genetic polymorphisms associated with obesity and obesity-related phenotypes and their use in predicting if an individual looses weight during a dietary weight loss intervention program.. .
12/04/14
20140356865
Methods and compositions for efficient base calling in sequencing reactions
The present invention is directed to methods and compositions for acquiring nucleotide sequence information of target sequences. In particular, the present invention provides methods and compositions for improving the efficiency of sequencing reactions by using fewer labels to distinguish between nucleotides and by detecting nucleotides at multiple detection positions in a target sequence..
12/04/14
20140356859
Detection of nucleic acids using unmodified gold nanoparticles
A gold nanoparticle-based colorimetric assay kit for nucleic acids from viral, bacterial and other microorganisms that detects unamplified or amplified polynucleotides in clinical specimens using unmodified aunps and oligotargeter polynucleotides that bind to a pathogen's nucleic acids. A method for detecting a pathogen comprising contacting a sample suspected of containing microbes with a polynucleotide that binds to pathogen nucleic acid and with gold nanoparticles, detecting the aggregation of nanoparticles, and detecting pathogen polynucleotides in the sample when the nanoparticles aggregate (solution color becomes blue) in comparison with a control or a negative sample not containing the virus when nanoparticles do not aggregate (solution color remains red)..
12/04/14
20140356413
Retinoid-liposomes for treating fibrosis
What is described are pharmaceutical compositions comprising a double-stranded nucleic acid molecule comprising a sense strand and an antisense strand wherein the sense and antisense strands are selected from the oligonucleotides described as serpinh1_2 (seq id nos: 60 and 127), serpinh1_45a (seq id nos: 98 and 165), and serpinh1_51 (seq id nos: 101 and 168), and drug carrier comprising a mixture of a retinoid and a lipid vesicle, and methods of using these pharmaceutical compositions to treat a disease associated with hsp47 espresssion, including fibrosis.. .
12/04/14
20140356363
Antigen binding proteins that bind pd-1
There is disclosed compositions and methods relating to or derived from anti-pd-1 antibodies. More specifically, there is disclosed fully human antibodies that bind pd-1, pd-1-binding fragments and derivatives of such antibodies, and pd-1-binding polypeptides comprising such fragments.
12/04/14
20140356362
Targeted/immunomodulatory fusion proteins and methods for making same
The present invention relates generally to the field of generating fusion proteins to be used in cancer therapy, and more specifically, to nucleotide sequences encoding the fusion proteins, wherein the chimeric fusion proteins comprises at least one targeting moiety and at least one immunomodulatory moiety that counteracts the immune tolerance of cancer cells.. .
12/04/14
20140356355
Il-17 receptor a antigen binding proteins
The present invention relates to il-17 receptor a (il-17ra or il-17r) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by il-17 receptor a activation by one or more il-17 ligands. The present invention relates to the identification of neutralizing determinants on il-17 receptor a (il-17ra or il-17r) and antibodies that bind thereto.
12/04/14
20140356346
Modified coagulation factor viia with extended half-life
The present invention relates to the fields of factor vii (fvii) and factor viia (fviia) albumin linked polypeptides. More specifically, the invention relates to cdna sequences coding for human factor vii and factor viia and derivatives genetically fused to a cdna coding for human serum albumin which may be linked by oligonucleotides which code for intervening peptidic linkers such encoded derivatives exhibiting improved stability and extended functional plasma half-life, recombinant expression vectors containing such cdna sequences, host cells transformed with such recombinant expression vectors, recombinant polypeptides and derivatives which do have biological activities of the unmodified wild type protein but having improved stability and prolonged shelf-life and processes for the manufacture of such recombinant proteins and their derivatives.
12/04/14
20140356342
Human beta-adrenergic receptor kinase polypeptide and methods
Various embodiments of the invention provide human kinases and phosphatases (kpp) polypeptides and polynucleotides which identify and encode kpp. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists.


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Nucleotide for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Nucleotide with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         



Key IP Translations - Patent Translations



0.4209

3668

2 - 1 - 77